Company Filing History:
Years Active: 2010-2012
Title: The Innovations of Stanislas Pol
Introduction
Stanislas Pol is a notable inventor based in Juvisy sur Orge, France. He has made significant contributions to the field of medical research, particularly in the treatment of infections and chronic diseases. With a total of 2 patents, his work has the potential to impact patient care and therapeutic strategies.
Latest Patents
Pol's latest patents include innovative methods for using sIP-10, CD26 inhibitors, and CXCR3 levels in samples to assess the clearance of infections and responses to interferon therapy. One of his inventions focuses on the treatment of infections using CD26 (DPIV) inhibitors. This invention also introduces an antibody that binds to the IP-10 protein, along with a method for monitoring the necessity of administering a CD26 inhibitor to patients by evaluating levels of sIP-10, CD26 activity, and CXCR3 cell levels in samples. Another patent involves methods of using sIP-10 to assess HCV clearance and predict clinical outcomes in patients by measuring levels of sIP-10 protein expression, as well as therapies utilizing sIP-10 and its fragments.
Career Highlights
Stanislas Pol is affiliated with the prestigious Institut Pasteur, where he conducts his research and develops his inventions. His work at this renowned institution underscores his commitment to advancing medical science and improving treatment options for patients.
Collaborations
Pol has collaborated with esteemed colleagues, including Matthew Albert and Jeremie Decalf. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in driving innovation.
Conclusion
Stanislas Pol's contributions to medical research through his patents and collaborations reflect his dedication to improving healthcare outcomes. His innovative methods have the potential to change the landscape of infection treatment and patient management.